The Pharma Squeeze Is On – They Want It All


“This is the time for preparation in a preventative manner to remain healthy.”


Oh, how I wish everything was sunshine and roses.

A very dear, long-time friend of mine died last week. She was slim, fit and very active and recently declared healthy by her medical doctor. Her sister gave me the news: she died suddenly and because it was puzzling, they were waiting for the autopsy report. I asked if she had taken the Covid injection. I was immediately told oh, she did not die from Covid since she recently had both injections. I thought immediately, of course she did not die from Covid but could it be from the double jab, I wondered, the answer I may never know.

A lot has been changing lately in Pharmaland and it looks like the current power they dictate does not seem to be enough. Pharma is not content to control the symptomatic treatment of disease anymore, they want it all, including control of your immunity. You would think that since pharma controls the health and wellbeing of the masses, they would be satisfied. According to the data from 2019, in the US alone “nearly nine in ten (89%) adults 65 and older report they are currently taking prescription medicine. This compares to three-fourths (75%) of 50–64-year-olds who report taking prescription drugs, half (51%) of 30–49-year-olds, and four in ten (38%) 18–29-year-olds. Older adults are also more likely than their younger counterparts to be taking multiple prescription medications. More than half of adults 65 and older (54%) report taking four or more prescription drugs compared to one-third of adults 50-64 years old (32%) and about one in ten adults 30-49 (13%) or 18-29 (7%).”[1]

The good thing is that people have begun to wake up and want to escape their dependency of being on multiple symptomatic treating drug therapy. They know that the core of their illness remains and they cope being a customer for life. These people turned to supplements to find answers drugs could not give them. Unfortunately, Pharma recognized the threat. Did you know that pharmaceutical companies have purchased almost all the major vitamin companies? You would not know it unless you searched to see who owns the companies making the supplements you may be taking. Of course, the official statement is that they do not influence the companies purchased, but ask yourself this question: whose interest do they have in mind the customer’s or the shareholder’s?

If a natural product works for keeping people healthy, pharma just may want to keep it for themselves or take it off the market and control the access and pricing. Often the form is critical for maintaining health such as Pyridoxal-5-Phosphate (P5P) – the active, predigested form of vitamin B6. It is a great example representing the problem we are describing.

A natural form of vitamin B6, pyridoxamine, was recently removed from the market by the FDA because a pharmaceutical company, BioStratum, wanted sole use of pyridoxamine in a drug. The company filed a so-called citizen’s petition and the FDA agreed.

Unfortunately, there is more bad news about vitamin B6. All forms of B6, natural or synthetic, must first be converted within the body to P5P, the natural form the body uses. The drug company Medicure Pharma wants sole use of P5P and so has petitioned the FDA to ban its use as a supplement as well. The tragedy is that at least 30 percent or more of the population cannot convert synthetic B6 pyridoxine to P5P. These individuals would have to solely rely on Medicure’s product to stay alive if the FDA grants their request. Their petition states: “Pharmaceutical companies developing new drugs must be protected from companies that may seek to market the ingredients in those drugs as dietary supplements. The marketing of such products has the potential to undermine the incentive for the development of new drugs because many people may choose to purchase the supplements rather than the drugs.”

Life Choice only uses the active form of P5P in all formulations with B6. We pay 400% more than we would for pyridoxine because it is delivered directly to the cells not requiring conversation in the body. It is completely safe for infants, pure USP pharmaceutical grade quality and effective without side effects. The same can not be stated for pyridoxine, actually in higher doses pyridoxine can be toxic.

P5P is not the only natural product that experiences difficulties on the supplement market. Medicinal grade DMSO is one of the most powerful natural anti-inflammatories and pain medications available today but its supply has become very scarce due to the Covid fiasco. Although the finished product is manufactured in the US, the intermediates needed to process DMSO come from several countries and their supply is also affected. As a result vendor prices have gone up 30%. Solvent grade DMSO from China is readily available, but it can be toxic.

In our previous newsletter we disclosed the scarcity of our patented, USP pharmaceutical grade Melapure® Melatonin. As pharma has secured most of the production, our raw material prices went up 100%.  Animal or unknown origin melatonin from China is readily available at 10% the cost but it carries a host of side-effects and it can shut down your own serotonin production.

According to the Alliance of Natural Health, “Melatonin has been found to inhibit the action of an inflammasome that is known to be involved in the exaggerated immune responses in the most critical coronavirus cases, NLRP3. Age-related decline in melatonin production has been proposed as one of the reasons the elderly seem to be affected more by COVID-19 than the young.”[2]

Those with their eyes open can see the squeeze pharma is making. This is the time for preparation in a preventative manner to remain healthy since the global response to the pandemic has and will cause further disruptions in supplies. Let’s get prepared.

If you missed our last newsletter in which we shared our Covid prevention protocol, this is the link:


References and Further Readings:



[1] Kirzinger, Ashley et al. 2019.

[2] See also: Hardeland, Rüdiger. 2018.